HEALTH.LONDON
Governance, safety & data

Who is accountable,
for what, and to whom.

A programme that handles genomes, ionising radiation, pigmented lesions, prescribing decisions and a continuous data stream has to be able to answer this page in a single breath.

Clinical governance

The structure

Accountability

Interpretation and clinical responsibility, separated

Dr. Mittal reads the data and designs the protocol. A named, employed, GMC-registered doctor holds clinical responsibility, prescribes, and signs. Both are named on your file and in your reports, and the distinction between them is stated to you, not blurred.

Oversight

Multidisciplinary review

Complex or discordant findings are reviewed by more than one clinician before advice is issued. Genomic findings are reviewed with a clinical geneticist or genetic counsellor. Imaging is reported by a consultant radiologist at our partner centre, and pigmented lesions by an external consultant dermatologist appointed by the practice.

Laboratories

Accredited testing only

Biochemistry and sequencing are placed with laboratories of our selection, accredited to ISO 15189 by UKAS or an equivalent body, chosen on capability rather than on a standing commercial relationship. Any research-grade assay is labelled as such on the report and is never used alone to drive a clinical decision.

Telemetry

Reviewed by the team, monthly with Dr. Mittal

The streams are reviewed by a named member of the clinical team on a continuing basis, and read in full with Dr. Mittal once a month. Thresholds that raise a flag are defined in writing, as is what is not watched. That document is what stops a member believing they are under continuous clinical observation when they are not, and it is the first thing a claimant's solicitor would ask for.

Devices

Consumer hardware, honestly classified

Each device is recorded with its regulatory status and intended use. Consumer wearables are not medical devices and their outputs are never entered into the record as diagnostic measurements. Firmware and algorithm changes are noted, because they break longitudinal comparability without warning.

Incidental findings

A written policy, agreed in advance

What we look for, what we report, what we do about an unexpected finding, and how quickly. Your elections on secondary genomic findings are recorded before sequencing, and can be revised.

Escalation

Urgent findings

Defined pathways and defined timescales for a result that needs same-day action, including direct referral into an appropriate acute service. This is not an emergency service and does not substitute for one.

MRI safety

Screening before every scan

Implants, devices, retained metal, pregnancy and claustrophobia are screened at booking and re-checked at the scanner. MR safety governance sits with the partner imaging centre, under its own named safety personnel and written procedures.

Imagery

Clinical photography discipline

Total body and scalp photography is clinical imaging, not marketing material. Fixed poses, fixed lighting, calibrated colour, encrypted storage, consent recorded separately, and an absolute bar on promotional use without specific written permission.

Audit

Measured against itself

Findings, actions taken and outcomes are audited annually — including how many MRI, dermoscopy and telemetry flags led to further investigation, and how many of those turned out to matter. Where the data shows a test is not earning its place, it is removed, and members are told.

Data protection

Genomic data is the most identifying
data a person has

Genetic and health data are special category personal data under the UK GDPR. Processing requires both a lawful basis under Article 6 and a separate condition under Article 9 — typically the provision of health care under Article 9(2)(h), supported by explicit consent for anything outside it. A data protection impact assessment is mandatory and must be completed before the first sample is taken. Continuous telemetry raises the stakes again: a year of glucose, sleep and location-adjacent timing data describes a person's private life in a way a blood panel does not. Everything stays in the United Kingdom.

Storage
All member data — sequence files, images, clinical photography and telemetry — is held encrypted in the United Kingdom. Nothing is stored outside it.
Device vendors
Every vendor is a processor and needs a written Article 28 agreement and a contractual bar on using member data for its own research or product development. Nothing is enrolled until you have been told who the manufacturer is and where it processes the data, and until you have consented to that specific device.
Access
Role-based, logged, and limited to those involved in your care. Access logs available to you on request.
Insurers
Health.London does not deal with insurers. Fees are not recoverable from private medical insurance, and no claim is submitted on your behalf. Your data is never disclosed to an insurer, an employer or any third party without your specific written instruction. Separately, and for your own reassurance rather than ours: under the UK Code on Genetic Testing and Insurance, insurers do not ask for or use predictive genetic test results, subject to one narrow published exception.
Research
No member's data is used for research, shared with a research partner, or commercialised in any form without separate, specific, revocable opt-in consent. Consent to the programme is not consent to research.
Retention and deletion
Everything is retained in the United Kingdom, under the periods set out in the privacy notice. On request, sequence data, images, telemetry and samples are destroyed, subject only to the clinical records the law requires to be kept.
Your rights
Access, rectification, erasure, restriction, portability and objection, exercised through a named data protection contact, with the right to complain to the Information Commissioner's Office.